Polynovo (Polynovo) Investments And Advances : $0.00 Mil (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Polynovo Investments And Advances?

Polynovo's Investments And Advances for the quarter that ended in Dec. 2023 was $0.00 Mil.

Polynovo's quarterly Investments And Advances increased from Dec. 2022 ($0.00 Mil) to Jun. 2023 ($0.38 Mil) but then declined from Jun. 2023 ($0.38 Mil) to Dec. 2023 ($0.00 Mil).

Polynovo's annual Investments And Advances increased from Jun. 2021 ($0.11 Mil) to Jun. 2022 ($0.21 Mil) and increased from Jun. 2022 ($0.21 Mil) to Jun. 2023 ($0.38 Mil).

Polynovo Investments And Advances Historical Data

The historical data trend for Polynovo's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Polynovo Investments And Advances Chart

Polynovo Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Investments And Advances

Get a 7-Day Free Trial

0.12

0.10

0.11

0.21

0.38

Polynovo Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Investments And Advances	Get a 7-Day Free Trial															-	0.21	-	0.38	-

Polynovo Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.

Polynovo (Polynovo) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Polynovo Ltd (OTCPK:CALZF) » Definitions » Investments And Advances

Comparable Companies

Traded in Other Exchanges

MFJ:Germany PNV:Australia

Address

320 Lorimer Street, Unit 2, Port Melbourne, VIC, AUS, 3207

Website

https://www.polynovo.com

Polynovo earns most of its revenue from U.S. sales of its NovoSorb Biodegradable Temporizing Matrix, or NovoSorb BTM. The product is a patented biodegradable synthetic scaffold to support the regeneration of the dermis when lost through surgery, trauma, burns, or other causes of tissue loss. Once the product is applied to a wound, it takes a few weeks for the dermal layer to fully integrate within the polymer scaffold before a clinician can delaminate the outer layer. A small wound would then close either naturally or with a dressing, while a larger wound would close through a split-skin graft or alternative product such as Avita's RECELL. NovoSorb BTM then slowly degrades to harmless byproducts which are fully absorbed in roughly 18 months.